Does LEUPROLIDE Cause Metastatic neoplasm? 84 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 84 reports of Metastatic neoplasm have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.1% of all adverse event reports for LEUPROLIDE.
84
Reports of Metastatic neoplasm with LEUPROLIDE
0.1%
of all LEUPROLIDE reports
25
Deaths
24
Hospitalizations
How Dangerous Is Metastatic neoplasm From LEUPROLIDE?
Of the 84 reports, 25 (29.8%) resulted in death, 24 (28.6%) required hospitalization.
Is Metastatic neoplasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 84 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Metastatic neoplasm?
BEVACIZUMAB (133)
TRASTUZUMAB (120)
CAPECITABINE (102)
PACLITAXEL (102)
CARBOPLATIN (89)
DOCETAXEL (72)
ADALIMUMAB (71)
RANITIDINE (71)
DENOSUMAB (68)
CLOZAPINE (65)
Which LEUPROLIDE Alternatives Have Lower Metastatic neoplasm Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM